Lenvatinib 4mg & Availability | Multikinase Inhibitor
Last Updated: July 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Rakib Uddin Ahmed, MBBS, MD (Hematology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from DRA and DGDA (Directorate General of Drug […]
Osimert 80 mg (Osimertinib) Supplier Lebanon
Last Updated: July 2026 Published by: Orio Pharma — a Bangladesh-based oncology medicine exporter serving hospitals, pharmacies, and distributors across Lebanon and worldwide. Medical Review: Reviewed by Dr. Farhan Hossain, MBBS, MD (Oncology) Content Basis: This article is based on official prescribing information and regulatory product documentation from the U.S. FDA and the European Medicines […]
Barigen 4 mg (Baricitinib) Tablets – Trusted Supplier in Saudi Arabia
Barigen 4 mg (Baricitinib) tablets are an oral, targeted anti-inflammatory therapy used in the management of moderate-to-severe rheumatoid arthritis and other immune-mediated conditions. As a Bangladesh-based exporter, Orio Pharma supplies Barigen and related baricitinib brands to hospitals, tender agents, and licensed pharmaceutical distributors across Saudi Arabia, where demand for high-quality Janus kinase (JAK) inhibitor therapy […]
Carboplatin Chemotherapy: FDA-Approved Oncology Solution
Last Updated: July 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Nusrat Jahan, MBBS, MD (Medical Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from the FDA, EMA, and DGDA (Directorate General […]
Cyclophosphamide Injection: FDA-Approved Alkylating Agent
Last Updated: July 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Farhan Hossain, MBBS, MD (Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from the FDA, EMA, and DGDA (Directorate General of […]
Osimert (Osimertinib): Third-Generation EGFR-TKI for NSCLC
Last Updated: July 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Farhan Hossain, MBBS, MD (Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory documentation from the FDA, EMA, and DGDA (Directorate General of Drug […]
Oxaliplatin (Oxator) – Platinum-Based Colorectal Cancer Chemotherapy
Last Updated: July 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Nusrat Jahan, MBBS, MD (Medical Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from the FDA, EMA, and DGDA (Directorate General […]
Tofacent 5 mg JAK Inhibitor: DMARD for RA & Inflammatory Conditions
Last Updated: July 2026 Published by: Orio Pharma — a specialist Bangladeshi pharmaceutical supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Rakib Uddin Ahmed, MBBS, MD (Hematology) Content Basis: This article is based on official prescribing information and regulatory product documentation from the FDA, EMA, and SFDA (Saudi Food and Drug […]
Letrozole (Lenor) 2.5mg: Aromatase Inhibitor for Breast Cancer
Last Updated: June 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Farhan Hossain, MBBS, MD (Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from the FDA, EMA, and DGDA (Directorate General of […]
Fulvestrant ER Antagonist: HR+ Breast Cancer Treatment
Last Updated: June 2026 Published by: Orio Pharma — a specialist oncology medicine supplier serving patients, pharmacies, and distributors worldwide. Medical Review: Reviewed by Dr. Farhan Hossain, MBBS, MD (Oncology) Content Basis: This article is based on official prescribing information, product monographs, and regulatory product documentation from the FDA, EMA, and DGDA (Directorate General of […]